| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/25/2002 | CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | CA2434490A1 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions |
| 07/25/2002 | CA2434350A1 Novel receptors for $i(helicobacter pylori) and use thereof |
| 07/25/2002 | CA2434270A1 Use of mesna compounds to prevent adverse reactions to anti-neoplastic compositions |
| 07/25/2002 | CA2433879A1 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | CA2433862A1 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | CA2433316A1 Molecular antigen array |
| 07/25/2002 | CA2431919A1 Ccr5 antagonist and dp-178 polypeptide for treating viral infections |
| 07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | CA2426775A1 Thienopyrimidine-based inhibitors of the src family |
| 07/25/2002 | CA2425135A1 Synthesis and antimicrobial activity of novel dicationic "reversed amidines" |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
| 07/24/2002 | EP1224941A2 Antithrombin III used in diseases caused by angiogenesis |
| 07/24/2002 | EP1224938A1 Gugulipid for treating cognitive disorders, hyperglycaemia and skin disorders |
| 07/24/2002 | EP1224288A2 Processed human chemokines phc-1 and phc-2 |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224274A1 Tumor necrosis factor related receptor, tr6 |
| 07/24/2002 | EP1224271A1 Expression of recombinant mature lysostaphin |
| 07/24/2002 | EP1224222A2 Chemokine receptor |
| 07/24/2002 | EP1224220A2 Epo primary response gene 1, eprg1 |
| 07/24/2002 | EP1224219A1 Beta-defensins |
| 07/24/2002 | EP1224214A1 Redox reversible hcv proteins with native-like conformation |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224203A2 Antisense modulation of protein kinase c-theta expression |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224200A1 Tissue plasminogen activator-like protease |
| 07/24/2002 | EP1224197A1 Hygromycin derivatives |
| 07/24/2002 | EP1224194A1 Hygromycin a prodrugs |
| 07/24/2002 | EP1224180A2 Substituted azoles |
| 07/24/2002 | EP1224177A1 Process for preparing oxazolines from tetrahydrofurans |
| 07/24/2002 | EP1224173A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 07/24/2002 | EP1224168A1 Antifungal enediynes |
| 07/24/2002 | EP1224163A1 Use of carbonylamino derivatives against cns disorders |
| 07/24/2002 | EP1224155A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 07/24/2002 | EP1223988A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 07/24/2002 | EP1223987A2 Method |
| 07/24/2002 | EP1223984A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 07/24/2002 | EP1223978A2 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 07/24/2002 | EP1223977A2 Modified plant viruses and methods of use thereof |
| 07/24/2002 | EP1223976A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 07/24/2002 | EP1223975A2 MUCOSAL DTPa VACCINES |
| 07/24/2002 | EP1223974A2 Medicament in order to induce tolerance |
| 07/24/2002 | EP1223973A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223949A1 Extended release formulations of erythromycin derivatives |
| 07/24/2002 | EP1223935A1 Methods of use of fluoroquinolone compounds against bacteria |
| 07/24/2002 | EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 07/24/2002 | EP1223929A1 Cannabimimetic indole derivatives |
| 07/24/2002 | EP1223928A2 Use of flavones, coumarins and related compounds to treat infections |
| 07/24/2002 | EP1223924A2 Use of csaids in rhinovirus infection |
| 07/24/2002 | EP1223921A2 Tissue factor antagonists and methods of use thereof |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP1059934B1 Matrix protein compositions for wound healing |
| 07/24/2002 | EP0826001B1 Acellular pertussis vaccines and methods of preparation thereof |
| 07/24/2002 | EP0814086B1 Antibiotics tkr1912-i and tkr1912-ii and process for producing the same |
| 07/24/2002 | CN1360678A Early detection of flaviviruses using NS1 glycoprotein |
| 07/24/2002 | CN1360638A Recombinant protein production in human cell using sequences encoding adenovirus E1 protein |
| 07/24/2002 | CN1360631A Methods and compositions for preventing formation of aberrant RNA during transcription of plasmid sequence |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360594A Attenuated microorganisms for treatment of infection |
| 07/24/2002 | CN1360593A Pseudomycin N-acyl side-chain analogs |
| 07/24/2002 | CN1360592A Streptogramin derivs., production thereof and composition contg. same |
| 07/24/2002 | CN1360590A Androgen glycosides and androgenic activity thereof |
| 07/24/2002 | CN1360588A Hemisynthetic method and intermediate thereof |
| 07/24/2002 | CN1360581A Benzoylpyridazines |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360567A Sphingoid base devivs. and uses thereof |
| 07/24/2002 | CN1360509A Herb medicine composition to be contained in sanitary materials for infants |
| 07/24/2002 | CN1360508A Herb medicine composition to be spread on sanitary napkin for female |
| 07/24/2002 | CN1360507A Conjugates and method for production thereof, and their use for transporting molecules via biological membranes |
| 07/24/2002 | CN1360505A Pseudomycin antifungal compositions and method for their use |
| 07/24/2002 | CN1360495A Intravaginal clindamycin ovule composition |
| 07/24/2002 | CN1360494A Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 07/24/2002 | CN1360493A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1360492A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1360467A Antimicrobial sanitizing lotion with skin protection properties |
| 07/24/2002 | CN1359730A Animal nipple degerming agent and method for improving germ environment |
| 07/24/2002 | CN1359725A Lotion for treating baby's cold |
| 07/24/2002 | CN1359719A Application of tea in preparing exterior-applied medicine of treating dermatopathy |
| 07/24/2002 | CN1359713A Medicine for treating syphilis |
| 07/24/2002 | CN1359691A Medicine for treating pulmonery tuberculosis |
| 07/24/2002 | CN1359689A Medicine for treating dysentery of animals and fowls and its preparing process |
| 07/24/2002 | CN1359678A Process for preparing houttuyninum sodium injection |
| 07/24/2002 | CN1359677A Preparation of propofol with enhanced bacteria inhibition |
| 07/24/2002 | CN1087953C Vaccine design and production |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423750 Systems for delivering anti-infective compositions to treat disordered tissue such as cold sores |
| 07/23/2002 | US6423748 Contact lenses antiseptic |
| 07/23/2002 | US6423744 Administering an amount of a leukotriene b4 (ltb4) antagonist, preferably a ltb4 receptor antagonistic, to a patient exhibiting adverse drug effect due to exogenous interleukin-2, to decrease the adverse effects |
| 07/23/2002 | US6423737 Benzamidoxime prodrugs as antipneumocystic agents |
| 07/23/2002 | US6423736 Administering benzimidazole compound |
| 07/23/2002 | US6423735 Administering benzimidazole compound |
| 07/23/2002 | US6423720 Pyrimidine compounds and methods for making and using the same |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423690 Antibacterial agents |
| 07/23/2002 | US6423687 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/23/2002 | US6423547 Non-covalent bioconjugates useful for diagnosis and therapy |
| 07/23/2002 | US6423545 Unmarked deletion mutants of mycobacteria and methods of using same |
| 07/23/2002 | US6423539 Enhancing immunology response |